Journal of Bacteriology and Infectious Diseases

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (629)348-3199

Editorial - Journal of Bacteriology and Infectious Diseases (2025) Volume 9, Issue 2

Beyond Antibiotics: Exploring Probiotics and Prebiotics to Combat Resistance

Richard Smith *

The Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, UK

*Corresponding Author:
Richard Smith
The Department of Non-communicable Disease Epidemiology,
London School of Hygiene and Tropical Medicine, UK
E-mail: smithR21@umich.mx

Received: 01-Jan-2025, Manuscript No. AABID-24-171172; Editor assigned: 03-Jan-2025, PreQC No. AABID-24-171172(PQ); Reviewed:16-Jan-2025, QC No. AABID-24-171172; Revised:18-Jan-2025, Manuscript No. AABID-24-171172(R); Published: 24-Jan-2025, DOI:10.35841/aabid-9.2.193

Citation: Smith R. Beyond antibiotics: Exploring probiotics and prebiotics to combat resistance. J Bacteriol Infec Dis. 2025; 9(2):193

Visit for more related articles at Journal of Bacteriology and Infectious Diseases

Introduction

Antibiotic resistance is one of the most pressing global health challenges of the 21st century. The overuse and misuse of antibiotics in medicine, agriculture, and animal husbandry have accelerated the emergence of multidrug-resistant pathogens, threatening the effectiveness of conventional treatments. As the world grapples with this crisis, researchers are turning to alternative strategies that support the body’s natural defenses. Among these, probiotics and prebiotics have emerged as promising tools to mitigate resistance and restore microbial balance [1].

Antibiotic resistance occurs when bacteria evolve mechanisms to withstand the drugs designed to kill them. This leads to longer hospital stays, higher medical costs, and increased mortality. According to the World Health Organization, antibiotic resistance could cause 10 million deaths annually by 2050 if left unchecked. The need for sustainable, non-antibiotic interventions has never been more urgent [2].

Probiotics are live microorganisms that, when administered in adequate amounts, confer health benefits to the host. Common strains include Lactobacillus, Bifidobacterium, and Saccharomyces boulardii. These microbes are typically found in fermented foods like yogurt, kefir, and kimchi. Prebiotics, on the other hand, are non-digestible food components—such as inulin, fructooligosaccharides (FOS), and galactooligosaccharides (GOS)—that selectively stimulate the growth of beneficial bacteria in the gut [3].

Numerous studies have demonstrated the efficacy of probiotics and prebiotics in reducing infection rates and antibiotic use: A randomized controlled trial showed that Lactobacillus rhamnosus GG reduced the incidence of antibiotic-associated diarrhea in children. Prebiotic supplementation with inulin has been linked to improved gut health and reduced inflammation in patients with irritable bowel syndrome [4].

Synbiotic formulations have shown promise in preventing ventilator-associated pneumonia in ICU patients Despite their potential, several challenges remain: Not all probiotics are equally effective. Identifying optimal strains for specific conditions is crucial. Variability in formulations, dosages, and delivery methods complicates clinical application. While generally safe, probiotics may pose risks for immunocompromised individuals. In many countries, probiotics and prebiotics are marketed as supplements, lacking rigorous oversight. Tailoring interventions based on individual microbiota profiles. Exploring synergistic effects with antibiotics to enhance efficacy and reduce resistance. Engineering strains with targeted antimicrobial properties. Establishing standardized protocols for clinical use [5].

Conclusion

The fight against antibiotic resistance requires a multifaceted approach. While antibiotics remain essential, their limitations necessitate complementary strategies. Probiotics and prebiotics offer a natural, sustainable, and effective means to support microbial health, enhance immunity, and reduce the burden of resistant infections. As research advances, these interventions may become integral to modern medicine—ushering in a new era of microbiome-centered therapeutics.

References

  1. Salmaso N, Boscaini A, Pindo M. Unraveling the diversity of eukaryotic microplankton in a large and deep perialpine lake using a high throughput sequencing approach. Front Microbiol. 2020;11:789.

    2. Indexed at, Google Scholar, Cross Ref

  2. Dheilly NM, Lucas P, Blanchard Y, et al. A world of viruses nested within parasites: unraveling viral diversity within parasitic flatworms (Platyhelminthes). Microbiol Spectr. 2022;10(3):e00138-22.

    3. Indexed at, Google Scholar, Cross Ref

  3. Kandasamy T, Ekbal S, Kumari K, et al. Unraveling bacterial diversity of the Indian Lac Insect Kerria lacca (Kerr) using next generation sequencing. Int J Trop Insect Sci. 2022;42(3):2365-72.

    4. Google Scholar

  4. Leung MH, Wilkins D, Li EK, et al. Indoor-air microbiome in an urban subway network: diversity and dynamics. Appl Environ Microbiol. 2014;80(21):6760-70.

    5. Indexed at, Google Scholar, Cross Ref

  5. Brunel C, Pouteau R, Dawson W, et al. Towards unraveling macroecological patterns in rhizosphere microbiomes. Trends Plant Sci. 2020;25(10):1017-29.

    6. Indexed at, Google Scholar, Cross Ref

Get the App